Nerea Fernández de Larrea-Baz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nerea Fernández de Larrea-Baz has a total of 248 co-authors. Here are the top co-authors by number of shared publications:
- Beatriz Pérez-Gómez
Department of Epidemiology of Chronic Diseases. National Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, 28029, Spain
25 shared publications - Marina Pollán
Department of Epidemiology of Chronic Diseases. National Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, 28029, Spain
24 shared publications - Virginia Lope
Cancer and Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III (ISCIII), Avda. Monforte de Lemos, 5, 28029, Madrid, Spain
16 shared publications - Nuria Aragonés
Cancer Surveillance and Registry Unit, General Directorate of Public Health, Madrid Health Department Madrid Spain
10 shared publications - Adela Castelló
Department of Chronic Diseases, National Centre for Epidemiology, Carlos III Institute of Health, Calle de Melchor Fernández Almagro, 5, 28029, Madrid, Spain
9 shared publications - Roberto Pastor-Barriuso
National Center for Epidemiology, Institute of Health Carlos III , Madrid
9 shared publications
Latest Publications
- Open Access
- 21 May 2026
- Published by Springer Nature in Breast Cancer Research
- Vol. 28 (1)
Adherence to the WCRF/AICR cancer prevention recommendations and mammographic density
Mammographic density (MD) is a known predictor of breast cancer risk and may be influenced by modifiable lifestyle factors. This study aimed to assess the association between adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations prior to diagnosis and MD in women diagnosed with breast cancer. We analyzed data from 759 breast cancer patients recruited from eight Spanish hospitals enrolled in the case-case Breast Cancer & Density Association Study. Participants completed an epidemiological and a food frequency questionnaire. A standardized score was constructed to assess adherence to six WCRF/AICR recommendations. MD percentage was measured using the validated DM-Scan software on the digital mammogram of the contralateral, tumor-free, breast obtained prior to any treatment. Standardized prevalences and standardized prevalence ratios (SPRs) for four MD categories and for MD ≥ 50% across categories of adherence to the WCRF/AICR recommendations were estimated based on multinomial and binary multivariable logistic regression models. Overall, adherence to the WCRF/AICR recommendations was not consistently associated with MD. However, the standardized prevalence of MD ≥ 50% was higher among women with high adherence compared to those with low adherence (SPR high vs. low = 1.73; 95% CI = 1.03-2.91). This positive association was particularly evident with the physical activity recommendation (SPR fully met vs. no/partially met = 1.51; 95% CI = 1.02-2.25). Breast cancer participants with greater adherence to the WCRF/AICR recommendations prior to diagnosis, particularly to physical activity guidelines, showed higher percent MD at diagnosis. This association likely reflects lower absolute breast adiposity rather than a greater amount of fibroglandular tissue, and would therefore not imply an increased carcinogenic risk. These findings highlight the complex relationship between lifestyle behaviors and breast tissue composition.
- 21 May 2026
- Published by Springer Nature in Breast Cancer Research
- Vol. 28 (1)
Open AccessAdherence to the WCRF/AICR cancer prevention recommendations and mammographic density
Mammographic density (MD) is a known predictor of breast cancer risk and may be influenced by modifiable lifestyle factors. This study aimed to assess the association between adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations prior to diagnosis and MD in women diagnosed with breast cancer. We analyzed data from 759 breast cancer patients recruited from eight Spanish hospitals enrolled in the case-case Breast Cancer & Density Association Study. Participants completed an epidemiological and a food frequency questionnaire. A standardized score was constructed to assess adherence to six WCRF/AICR recommendations. MD percentage was measured using the validated DM-Scan software on the digital mammogram of the contralateral, tumor-free, breast obtained prior to any treatment. Standardized prevalences and standardized prevalence ratios (SPRs) for four MD categories and for MD ≥ 50% across categories of adherence to the WCRF/AICR recommendations were estimated based on multinomial and binary multivariable logistic regression models. Overall, adherence to the WCRF/AICR recommendations was not consistently associated with MD. However, the standardized prevalence of MD ≥ 50% was higher among women with high adherence compared to those with low adherence (SPR high vs. low = 1.73; 95% CI = 1.03-2.91). This positive association was particularly evident with the physical activity recommendation (SPR fully met vs. no/partially met = 1.51; 95% CI = 1.02-2.25). Breast cancer participants with greater adherence to the WCRF/AICR recommendations prior to diagnosis, particularly to physical activity guidelines, showed higher percent MD at diagnosis. This association likely reflects lower absolute breast adiposity rather than a greater amount of fibroglandular tissue, and would therefore not imply an increased carcinogenic risk. These findings highlight the complex relationship between lifestyle behaviors and breast tissue composition.
- Open Access
- 11 March 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Biological Signatures of Inflammation Biomarkers Identified Using Data Reduction Methods in Adult Population: A Scoping Review Protocol
Background and Aims: Chronic inflammation contributes to various chronic diseases, emphasizing the need for reliable biomarkers for early detection and understanding its causes. Measuring chronic inflammation poses challenges since most biomarkers are influenced by both acute and chronic states and recent exposures. Joint analysis of inflammatory biomarkers may help identify specific biological signatures linked to chronic inflammation. The scoping review whose protocol is described here, aims to map the existing literature identifying these signatures in adults using data reduction methods in epidemiological studies. Methods: The review will follow the Joanna Briggs Institute methodology and the extension for Scoping Reviews of the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis checklist (PRISMA‐ScR). An electronic search will be performed in Medline (via PubMed) and Embase (via Elsevier) for studies published until October 2023, using relevant terms related to inflammation biomarkers, and data reduction methods. Eligible studies include systematic reviews and primary experimental, quasi‐experimental, and observational research analyzing inflammation biomarkers in blood, urine, or saliva from adults. Studies focused on acute infectious diseases, transient inflammatory conditions, and those not published in English or Spanish will be excluded. Four independent reviewers will conduct a two‐phase screening of studies (title/abstract and full‐text), with a third reviewer resolving disagreements. Data extraction will be handled by one reviewer and verified by another using a predefined form. Results: Findings will be summarized in a PRISMA flowchart. Interactive visual maps will illustrate the identified inflammatory signatures, categorized by study design, data reduction method, population type, and clinical condition. All resources will be publicly available. Conclusion: This review will provide a comprehensive overview of inflammation biomarker signatures derived from data reduction methods while identifying existing knowledge gaps in the field. Scoping Review Registration: This protocol was registered on January 25, 2024, on Open Science Framework ( https://doi.org/10.17605/OSF.IO/85XUF ).
- 11 March 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Open AccessBiological Signatures of Inflammation Biomarkers Identified Using Data Reduction Methods in Adult Population: A Scoping Review Protocol
Background and Aims: Chronic inflammation contributes to various chronic diseases, emphasizing the need for reliable biomarkers for early detection and understanding its causes. Measuring chronic inflammation poses challenges since most biomarkers are influenced by both acute and chronic states and recent exposures. Joint analysis of inflammatory biomarkers may help identify specific biological signatures linked to chronic inflammation. The scoping review whose protocol is described here, aims to map the existing literature identifying these signatures in adults using data reduction methods in epidemiological studies. Methods: The review will follow the Joanna Briggs Institute methodology and the extension for Scoping Reviews of the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis checklist (PRISMA‐ScR). An electronic search will be performed in Medline (via PubMed) and Embase (via Elsevier) for studies published until October 2023, using relevant terms related to inflammation biomarkers, and data reduction methods. Eligible studies include systematic reviews and primary experimental, quasi‐experimental, and observational research analyzing inflammation biomarkers in blood, urine, or saliva from adults. Studies focused on acute infectious diseases, transient inflammatory conditions, and those not published in English or Spanish will be excluded. Four independent reviewers will conduct a two‐phase screening of studies (title/abstract and full‐text), with a third reviewer resolving disagreements. Data extraction will be handled by one reviewer and verified by another using a predefined form. Results: Findings will be summarized in a PRISMA flowchart. Interactive visual maps will illustrate the identified inflammatory signatures, categorized by study design, data reduction method, population type, and clinical condition. All resources will be publicly available. Conclusion: This review will provide a comprehensive overview of inflammation biomarker signatures derived from data reduction methods while identifying existing knowledge gaps in the field. Scoping Review Registration: This protocol was registered on January 25, 2024, on Open Science Framework ( https://doi.org/10.17605/OSF.IO/85XUF ).
- Open Access
- 24 February 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Evolution of outdoor sports during the COVID-19 post-lockdown in Spain: a nationwide population-based study
Measures implemented to control the first wave of the COVID-19 pandemic influenced physical activity, including participation in sports. However, how long
- 24 February 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Open AccessEvolution of outdoor sports during the COVID-19 post-lockdown in Spain: a nationwide population-based study
Measures implemented to control the first wave of the COVID-19 pandemic influenced physical activity, including participation in sports. However, how long
- Open Access
- 24 September 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9346
Biomarkers for Personalised Primary or Secondary Prevention in Cardiovascular Diseases: A Rapid Scoping Review
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality globally. Early detection and personalised prevention strategies are crucial for reducing the burden of CVD. The use of biomarkers plays a pivotal role in identifying individuals at risk and facilitating timely interventions. This rapid scoping review aims to identify and evaluate current research on biomarkers used for primary and secondary personalised prevention of CVD, highlighting evidence gaps and the integration of digital technologies. A comprehensive search was conducted in Medline and Embase databases from January 2020 to February 2023. Joanna Briggs Institute (JBI) Manual for Evidence Synthesis and PRISMA-ScR guidelines were followed. A total of 775 studies were included, with ischemic heart disease (IHD) and stroke being the most investigated CVDs. Molecular, cellular, imaging, physiological, and anthropometric biomarkers were included. Molecular biomarkers, particularly genetic and biochemical, were the most researched. For secondary prevention, there was considerable research using imaging biomarkers. Genetic biomarker research was the most frequent category of biomarker identified, particularly using variant analysis and polygenic scores, followed by biochemical, imaging, and physiological biomarkers. There was also evidence of the integration of artificial intelligence to enhance the predictive capabilities of these biomarkers. Despite progress, research gaps were identified for less common CVDs, such as aortic aneurysm and nonrheumatic valvular heart disease, and limited research investigating other molecular biomarker types, such as epigenetics and transcriptomics.
- 24 September 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9346
Open AccessBiomarkers for Personalised Primary or Secondary Prevention in Cardiovascular Diseases: A Rapid Scoping Review
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality globally. Early detection and personalised prevention strategies are crucial for reducing the burden of CVD. The use of biomarkers plays a pivotal role in identifying individuals at risk and facilitating timely interventions. This rapid scoping review aims to identify and evaluate current research on biomarkers used for primary and secondary personalised prevention of CVD, highlighting evidence gaps and the integration of digital technologies. A comprehensive search was conducted in Medline and Embase databases from January 2020 to February 2023. Joanna Briggs Institute (JBI) Manual for Evidence Synthesis and PRISMA-ScR guidelines were followed. A total of 775 studies were included, with ischemic heart disease (IHD) and stroke being the most investigated CVDs. Molecular, cellular, imaging, physiological, and anthropometric biomarkers were included. Molecular biomarkers, particularly genetic and biochemical, were the most researched. For secondary prevention, there was considerable research using imaging biomarkers. Genetic biomarker research was the most frequent category of biomarker identified, particularly using variant analysis and polygenic scores, followed by biochemical, imaging, and physiological biomarkers. There was also evidence of the integration of artificial intelligence to enhance the predictive capabilities of these biomarkers. Despite progress, research gaps were identified for less common CVDs, such as aortic aneurysm and nonrheumatic valvular heart disease, and limited research investigating other molecular biomarker types, such as epigenetics and transcriptomics.
- Open Access
- 1 July 2025
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 11 (1) , e60658
Influenza Vaccination Coverage and Determinants of New Vaccinations During the COVID-19 Pandemic in Spain (ENE-COVID): Nationwide Population-Based Study
Background: Influenza vaccination coverage is commonly suboptimal. However, the COVID-19 pandemic and consequent high exposure to health information may have changed population attitudes toward this vaccination. Objective: The aim of this study is to describe influenza vaccine uptake in Spain during the first influenza season following the start of the COVID-19 pandemic compared to the previous one and identify characteristics associated with vaccination among those previously unvaccinated. Methods: This was a population-based study of 28,987 adults included in influenza vaccination target groups (≥65 years old, with risk conditions, living with someone with risk conditions, health care workers, security or emergency workers) who were participants in the nationwide Seroepidemiological Survey of SARS-CoV-2 Infection in Spain (ENE-COVID) study. Information on vaccination and sociodemographic, health, and COVID-19–related factors was collected by interview. Coverage change from 2019 to 2020 and standardized prevalences of vaccination in 2020 among the population unvaccinated in 2019 were estimated using logistic model–based methods. Results: Coverage rose from 31.4% (95% CI 30.5%‐32.2%) to 46.8% (95% CI 45.8%‐47.8%). People ≥65 years old showed the highest uptake in both periods (58.3%, 95% CI 56.8%‐59.8% and 74.8%, 95% CI 73.5%‐76.1%), while health care workers had the greatest increase (22%, 95% CI 17.8%‐26.2%). Among people unvaccinated in 2019, factors associated with vaccination in 2020 were age, female sex, higher education, Spanish nationality, multimorbidity, being a former smoker, obesity, contact with COVID-19 cases, living with older adults, living in provinces with low COVID-19 incidence, wearing a face mask during family meetings, and using surgical/FFP2 masks. Conclusions: This study provides nationwide representative estimates of influenza vaccination coverage, which clearly increased between 2019 and 2020 in the 5 target groups. However, coverage goals were attained only in the ≥65 year old group, highlighting the importance of reinforcing influenza vaccination. Our detailed results on determinants of vaccination provide some clues to tailor vaccination strategies.
- 1 July 2025
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 11 (1) , e60658
Open AccessInfluenza Vaccination Coverage and Determinants of New Vaccinations During the COVID-19 Pandemic in Spain (ENE-COVID): Nationwide Population-Based Study
Background: Influenza vaccination coverage is commonly suboptimal. However, the COVID-19 pandemic and consequent high exposure to health information may have changed population attitudes toward this vaccination. Objective: The aim of this study is to describe influenza vaccine uptake in Spain during the first influenza season following the start of the COVID-19 pandemic compared to the previous one and identify characteristics associated with vaccination among those previously unvaccinated. Methods: This was a population-based study of 28,987 adults included in influenza vaccination target groups (≥65 years old, with risk conditions, living with someone with risk conditions, health care workers, security or emergency workers) who were participants in the nationwide Seroepidemiological Survey of SARS-CoV-2 Infection in Spain (ENE-COVID) study. Information on vaccination and sociodemographic, health, and COVID-19–related factors was collected by interview. Coverage change from 2019 to 2020 and standardized prevalences of vaccination in 2020 among the population unvaccinated in 2019 were estimated using logistic model–based methods. Results: Coverage rose from 31.4% (95% CI 30.5%‐32.2%) to 46.8% (95% CI 45.8%‐47.8%). People ≥65 years old showed the highest uptake in both periods (58.3%, 95% CI 56.8%‐59.8% and 74.8%, 95% CI 73.5%‐76.1%), while health care workers had the greatest increase (22%, 95% CI 17.8%‐26.2%). Among people unvaccinated in 2019, factors associated with vaccination in 2020 were age, female sex, higher education, Spanish nationality, multimorbidity, being a former smoker, obesity, contact with COVID-19 cases, living with older adults, living in provinces with low COVID-19 incidence, wearing a face mask during family meetings, and using surgical/FFP2 masks. Conclusions: This study provides nationwide representative estimates of influenza vaccination coverage, which clearly increased between 2019 and 2020 in the 5 target groups. However, coverage goals were attained only in the ≥65 year old group, highlighting the importance of reinforcing influenza vaccination. Our detailed results on determinants of vaccination provide some clues to tailor vaccination strategies.
- Open Access
Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research Recommendations in Women with Breast Cancer
Background/Objectives: The 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations benefit primary prevention and survivor outcomes. This study evaluated the adherence to these recommendations during the year prior to breast cancer diagnosis and identified related clinical and sociodemographic factors. Methods: A total of 915 patients with breast cancer were recruited from eight hospitals in four regions of Spain. The participants completed an epidemiologic questionnaire and a food frequency questionnaire. The compliance with the WCRF/AICR recommendations was assessed using a standardized score based on seven recommendations. Standardized prevalences and standardized prevalence ratios (SPRs) for moderate and high adherence were calculated based on participant characteristics using binary and multinomial logistic regression models. Results: The mean adherence was 3.5 points out of 7. The recommendations with the best and worst adherence were avoiding sugar-sweetened drinks (54.4% adherence) and maintaining a fiber-rich diet (4.4% consumed ≥30 g/day). The overall adherence was better in women aged ≥60 years (SPR = 1.55; 95% CI = 1.09–2.22), and worse in those with a caloric intake ≥2000 kcal/day (SPR = 0.48; 95% CI = 0.37–0.62) or ≥2 comorbidities (SPR = 0.66; 95% CI = 0.49–0.89). The adherence to maintaining a healthy weight was worse in those with ≥2 comorbidities and stage III-IV tumors. The physical activity adherence was worse in working women and those with ≥2 comorbidities. The alcohol restriction adherence was worse in smokers. Younger women, smokers and those with a low calorie intake were less adherent to the fruit/vegetable recommendation. The consumption of fiber and limited consumption of red/processed meat adherence was poor in all the subgroups. The adherence to a limited consumption of fast food and sugary drinks was worse in younger women and high-calorie-diet consumers. Conclusions: The differences in the adherence to recommendations according to patient characteristics justify the design of personalized interventions for breast cancer patients.
Open AccessDeterminants of Adherence to World Cancer Research Fund/American Institute for Cancer Research Recommendations in Women with Breast Cancer
Background/Objectives: The 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations benefit primary prevention and survivor outcomes. This study evaluated the adherence to these recommendations during the year prior to breast cancer diagnosis and identified related clinical and sociodemographic factors. Methods: A total of 915 patients with breast cancer were recruited from eight hospitals in four regions of Spain. The participants completed an epidemiologic questionnaire and a food frequency questionnaire. The compliance with the WCRF/AICR recommendations was assessed using a standardized score based on seven recommendations. Standardized prevalences and standardized prevalence ratios (SPRs) for moderate and high adherence were calculated based on participant characteristics using binary and multinomial logistic regression models. Results: The mean adherence was 3.5 points out of 7. The recommendations with the best and worst adherence were avoiding sugar-sweetened drinks (54.4% adherence) and maintaining a fiber-rich diet (4.4% consumed ≥30 g/day). The overall adherence was better in women aged ≥60 years (SPR = 1.55; 95% CI = 1.09–2.22), and worse in those with a caloric intake ≥2000 kcal/day (SPR = 0.48; 95% CI = 0.37–0.62) or ≥2 comorbidities (SPR = 0.66; 95% CI = 0.49–0.89). The adherence to maintaining a healthy weight was worse in those with ≥2 comorbidities and stage III-IV tumors. The physical activity adherence was worse in working women and those with ≥2 comorbidities. The alcohol restriction adherence was worse in smokers. Younger women, smokers and those with a low calorie intake were less adherent to the fruit/vegetable recommendation. The consumption of fiber and limited consumption of red/processed meat adherence was poor in all the subgroups. The adherence to a limited consumption of fast food and sugary drinks was worse in younger women and high-calorie-diet consumers. Conclusions: The differences in the adherence to recommendations according to patient characteristics justify the design of personalized interventions for breast cancer patients.
- Open Access
- 24 January 2025
- Published by Elsevier in Public Health
- Vol. 239, 169-178
Intake of fruit, vegetables and pulses, and all-cause, cardiovascular and cancer mortality: Results from a population-based prospective study
- 24 January 2025
- Published by Elsevier in Public Health
- Vol. 239, 169-178
Open AccessIntake of fruit, vegetables and pulses, and all-cause, cardiovascular and cancer mortality: Results from a population-based prospective study
- 27 June 2024
- Published by Elsevier in Science of The Total Environment
- Vol. 946, 174347
Risk of prostate cancer in the proximity of industrial installations: A multicase-control study in Spain (MCC-Spain)
- 27 June 2024
- Published by Elsevier in Science of The Total Environment
- Vol. 946, 174347
Risk of prostate cancer in the proximity of industrial installations: A multicase-control study in Spain (MCC-Spain)
- 12 April 2024
- Published by Elsevier in Science of The Total Environment
- Vol. 928, 172463
Residential exposure to traffic pollution and mammographic density in premenopausal women
- 12 April 2024
- Published by Elsevier in Science of The Total Environment
- Vol. 928, 172463
Residential exposure to traffic pollution and mammographic density in premenopausal women
- 11 March 2023
- Published by Elsevier in Science of The Total Environment
- Vol. 876, 162768
Mammographic density in the environs of multiple industrial sources
- 11 March 2023
- Published by Elsevier in Science of The Total Environment
- Vol. 876, 162768
Mammographic density in the environs of multiple industrial sources